• Health & Medicine

Immunotherapy trial shows promise for some women with an aggressive breast cancer

An immunotherapy drug has shown promise for the first time in a form of aggressive breast cancer. An immunotherapy drug has shown promise for the first time in a form of aggressive breast cancer.

23 October 2018

• Health & Medicine

‘Cutting edge’ CAR T cell immunotherapy approved in England. But is the NHS ready?

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments. With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

5 October 2018

• Health & Medicine

NHS England to fund engineered cell therapy for adults with aggressive lymphoma

A cancer immunotherapy will be offered on the NHS in England to some adults with aggressive non-Hodgkin lymphoma, NHS England announced today. A cancer immunotherapy will be offered on the NHS in England to some adults with aggressive non-Hodgkin lymphoma, NHS England announced today.

5 October 2018

• Health & Medicine

Nobel Prize 2018: How Allison and Honjo turned immune cells against cancer

Dr James Allison and Professor Tasuku Honjo have been given a Nobel Prize for revolutionising our understanding of how the immune system sees cancer. Dr James Allison and Professor Tasuku Honjo have been given a Nobel Prize for revolutionising our understanding of how the immune system sees cancer.

1 October 2018

• Health & Medicine

Urine liquid biopsies could help monitor bladder cancer treatment

Scientists have shown for the first time that immune cells in the urine of bladder cancer patients accurately reflect those in the tumour environment. Scientists have shown for the first time that immune cells in the urine of bladder cancer patients accurately reflect those in the tumour environment.

26 September 2018

• Health & Medicine

Liver cancer: UK’s fastest rising cause of cancer death to be tackled

A joint UK and European research project launches today to combat liver cancer, which is the fastest rising cause of cancer death in the UK. A joint UK and European research project launches today to combat liver cancer, which is the fastest rising cause of cancer death in the UK.

20 September 2018

• Health & Medicine

Engineered cell therapy given initial ‘no’ for aggressive adult lymphoma on NHS in England

A cancer immunotherapy has been provisionally rejected as a treatment for some adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England. A cancer immunotherapy has been provisionally rejected as a treatment for some adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England.

19 September 2018

• Health & Medicine

NHS England to fund personalised blood cancer immunotherapy

A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today. A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today.

5 September 2018

• Health & Medicine

Engineered cell therapy given initial ‘no’ for NHS in England

A cancer immunotherapy has been provisionally rejected as a treatment for some types of aggressive non-Hodgkin lymphoma on the NHS in England. A cancer immunotherapy has been provisionally rejected as a treatment for some types of aggressive non-Hodgkin lymphoma on the NHS in England.

30 August 2018

• Health & Medicine

Immunotherapy drug made available for some NHS patients with Hodgkin lymphoma

The immunotherapy drug pembrolizumab (Keytruda) can now be used to treat some patients with Hodgkin lymphoma on the NHS in England. The immunotherapy drug pembrolizumab (Keytruda) can now be used to treat some patients with Hodgkin lymphoma on the NHS in England.

27 July 2018

• Health & Medicine

Cancer Research UK tests first of its kind vaccine to treat lung cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer. A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

12 June 2018

• Health & Medicine

Lung cancer immunotherapy drug approved for England

The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached. The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached.

6 June 2018